175 related articles for article (PubMed ID: 36625832)
1. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine.
Nomura J; Seki M; Abe S; Kobayashi T; Okitsu Y; Fukuhara N; Takahashi S; Harigae H; Kameoka J
Hum Vaccin Immunother; 2023 Dec; 19(1):2165381. PubMed ID: 36625832
[TBL] [Abstract][Full Text] [Related]
2. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report.
Khatri JK; Tahboub I; Anwar K; Masoudi M; Graffeo V; Jamil MO
J Investig Med High Impact Case Rep; 2024; 12():23247096241231645. PubMed ID: 38761096
[TBL] [Abstract][Full Text] [Related]
4. Acute pancreatitis in pregnancy following COVID-19 vaccine: a case report.
Dey RK; Ilango H; Bhatta S; Shaheed A; Dole S; Zooshan A; Faisham M; Murad M
J Med Case Rep; 2022 Sep; 16(1):354. PubMed ID: 36175940
[TBL] [Abstract][Full Text] [Related]
5. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine: Correspondence.
Pan W; Yu D; Shi N; Bao Z
Hum Vaccin Immunother; 2023 Dec; 19(3):2286117. PubMed ID: 37992397
[No Abstract] [Full Text] [Related]
6. Exacerbations of Idiopathic Systemic Capillary Leak Syndrome following BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech).
Akiyama Y; Inagaki T; Morioka S; Kusano E; Ohmagari N
Intern Med; 2023 Jul; 62(13):2013-2017. PubMed ID: 37081683
[TBL] [Abstract][Full Text] [Related]
7. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.
Singh RB; Parmar UPS; Kahale F; Agarwal A; Tsui E
Ophthalmology; 2023 Feb; 130(2):179-186. PubMed ID: 36055601
[TBL] [Abstract][Full Text] [Related]
9. A prospective study on myocardial injury after BNT162b2 mRNA COVID-19 fourth dose vaccination in healthy persons.
Levi N; Moravsky G; Weitsman T; Amsalem I; Bar-Sheshet Itach S; Algur N; Lapidus I; Mitz O; Glikson M; Wiener-Well Y; Hasin T
Eur J Heart Fail; 2023 Feb; 25(2):313-318. PubMed ID: 36097844
[TBL] [Abstract][Full Text] [Related]
10. mRNA COVID-19 Vaccine-Associated Subserosal Eosinophilic Gastroenteritis: A Case Report.
Lee JY; Lee JH
J Korean Med Sci; 2022 Aug; 37(30):e233. PubMed ID: 35916045
[TBL] [Abstract][Full Text] [Related]
11. Relapse of Evans syndrome following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine: case report and literature review.
Cvetković M; Pantić N; Virijević M; Pravdić Z; Sabljić N; Mitrović M; Suvajdžić-Vuković N
J Infect Dev Ctries; 2023 Jun; 17(6):800-804. PubMed ID: 37406068
[TBL] [Abstract][Full Text] [Related]
12. Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine.
Muhamad Fauzi SM
BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36882264
[TBL] [Abstract][Full Text] [Related]
13. [Allergy to Pfizer-BioNTech® vaccine demonstrated by skin testing].
Estrada-García CD; Macías-Robles AP; Cortés-Grimaldo RM; Carvajal-Alonso HL; Barreto-Alcalá M; Ramírez-Nepomuceno A; Esparza-Amaya D; Coronado-Hernández KG; Barrios-Díaz B; Campos-Téllez HH
Rev Alerg Mex; 2023 Jan; 69(2):89-92. PubMed ID: 36928249
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Course of New-Onset Ocular Myasthenia Gravis Caused by Pfizer-BioNTech COVID-19 Vaccine.
Su WY; Lu CJ
Acta Neurol Taiwan; 2023 Dec; 32(4)():218-222. PubMed ID: 37723915
[TBL] [Abstract][Full Text] [Related]
15. New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.
Osada A; Sakuragi C; Toya C; Mitsuo A
Intern Med; 2022 Mar; 61(5):749-753. PubMed ID: 34897152
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Polack FP; Thomas SJ; Kitchin N; Absalon J; Gurtman A; Lockhart S; Perez JL; Pérez Marc G; Moreira ED; Zerbini C; Bailey R; Swanson KA; Roychoudhury S; Koury K; Li P; Kalina WV; Cooper D; Frenck RW; Hammitt LL; Türeci Ö; Nell H; Schaefer A; Ünal S; Tresnan DB; Mather S; Dormitzer PR; Şahin U; Jansen KU; Gruber WC;
N Engl J Med; 2020 Dec; 383(27):2603-2615. PubMed ID: 33301246
[TBL] [Abstract][Full Text] [Related]
18. Vulvar Aphthous Ulcer Following Pfizer-BioNTech COVID-19 Vaccine - A Case Report.
Drucker A; Corrao K; Gandy M
J Pediatr Adolesc Gynecol; 2022 Apr; 35(2):165-166. PubMed ID: 34718079
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
[TBL] [Abstract][Full Text] [Related]
20. Childhood primary angiitis of the central nervous system following COVID-19 vaccination (BNT162b2/Pfizer-BioNtech): A case report.
Ariyoshi T; Hoshide M; Motonaga T; Korenaga Y; Azuma Y; Ichimura T; Matsushige T; Hasegawa S
Hum Vaccin Immunother; 2023 Aug; 19(2):2261167. PubMed ID: 37772503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
